SINTX TECHNOLOGIES INC (SINT)
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
$1.66-3.49%
Close 2026-11-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
QuarterlyIQ Insights · SINT
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||
| Revenues | 1.3 | 1.0 | 2.9 | 2.6 | 1.6 | 0.6 | 0.6 | 0.7 | 0.1 | 11.2 | 15.2 | 19.5 | 22.8 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 11.2 | 15.2 | 19.5 | 22.8 |
| Cost of Revenues | 0.6 | 0.6 | 0.8 | 0.8 | 0.3 | 0.4 | 0.5 | 0.6 | 0.1 | 6.4 | 3.8 | 6.3 | 7.9 |
| Gross Profit | 0.7 | 0.5 | 2.1 | 1.8 | 1.3 | 0.2 | 0.1 | 0.1 | 0.0 | 4.9 | 11.4 | 13.2 | 14.9 |
| Operating Expenses & Income | |||||||||||||
| R&D Expenses | 3.2 | 4.6 | 5.2 | 8.7 | 6.5 | 5.9 | 4.8 | 3.4 | 3.0 | 3.5 | 6.3 | 6.4 | 6.7 |
| Operating Income | (11.8) | (10.7) | (14.0) | (13.4) | (11.3) | (10.6) | (8.5) | (6.6) | (13.1) | (7.5) | (11.5) | (12.0) | (24.2) |
| Earnings from Continuing Operations | |||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | — | — | — | — | 3.7 |
| Interest & Investment Income | — | — | — | — | — | — | — | — | — | — | — | — | 0.0 |
| Net Interest Expenses | — | — | — | — | — | — | — | — | — | — | — | — | 3.6 |
| Other Non-Operating Income / Expenses | 0.5 | 0.4 | 3.0 | 5.1 | (0.7) | 1.3 | 1.5 | 1.8 | 3.4 | 1.7 | (3.2) | (11.9) | (8.4) |
| Asset Writedown | — | 0.1 | 4.6 | — | — | — | — | — | — | 0.9 | 0.9 | — | — |
| EBT, Incl. Unusual Items | (11.3) | (10.4) | (11.0) | (8.3) | (12.0) | (9.3) | (7.0) | (4.8) | (9.7) | (5.8) | (14.8) | (23.9) | (32.6) |
| Earnings from Continuing Operations | — | — | — | — | — | — | — | (4.8) | (9.7) | — | — | — | — |
| Net Income | |||||||||||||
| Net Income | (11.3) | (10.4) | (11.0) | (8.3) | (12.0) | (9.3) | (7.0) | (4.8) | (8.7) | (9.3) | (14.8) | (23.9) | (32.6) |
| Per Share | |||||||||||||
| Basic EPS | (2.33) | (6.16) | (14.87) | (443.47) | (54.67) | (37.70) | (1.01) | (4.82) | (61.85) | — | — | — | — |
| Diluted EPS | (2.33) | (6.16) | (15.19) | (624.47) | (60.81) | (39.91) | (1.08) | (5.69) | (76.73) | — | — | — | — |
| Revenue per Share | 0.27 | — | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 4.8 | 2.8 | 0.7 | 0.0 | 0.3 | 0.2 | 16.4 | 1.6 | 0.4 | — | — | — | — |
| Diluted Weighted Avg Shares | 4.8 | 2.8 | 0.7 | 0.0 | 0.3 | 0.3 | 17.4 | 1.6 | 0.4 | — | — | — | — |
| Supplemental | |||||||||||||
| EBIT | (11.8) | (10.7) | (14.0) | (13.4) | (11.3) | (10.6) | (8.5) | (6.6) | (13.1) | (7.5) | (11.5) | (12.0) | (24.2) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.